HIV-infected individuals with the CCR5Δ32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 1, 1997, Pages 10-14

  Katzenstein, Terese L ^a   Eugen Olsen, Jesper ^b   Hofmann, Bo ^b   Benfield, Thomas ^b   Pedersen, Court ^c   Iversen, Astrid K N ^a   Sørensen, Anne Marie ^b   Garred, Peter ^a   Koppelhus, Uffe ^b   Svejgaard, Arne ^a   Gerstoft, Jan ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CCR5; CD4 cells; Clinical progression; HIV RNA Viral load

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; COHORT ANALYSIS; GENOTYPE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECEPTOR GENE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 12644259502     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199709010-00002     Document Type: Article

References (14)

1. Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996;10:167-73.
2. Mellors JW, Rinaldo CR, Gupta P, White RW, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
3. Pedersen C, Katzenstein T, Nielsen C, Lundgren JD, Gerstoft J. Events in early HIV infection determine the long term outcome of the infection [abstract Mo.B.1341]. Presented at the XI International Conference on AIDS, Vancouver, July 1996.
4. Maddon PJ, Dalgleish AG, McDoougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47:333-48.
5. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: A RANTES, MIP-1α. MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
6. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
7. Deng HK, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
8. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-7.
9. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
10. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-a coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
11. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
12. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;1240-3.
13. Eugen-Olsen J, Iversen AKN, Garred P, et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS free survival and slower CD4 T cell fall in a cohort followed for 11 years. AIDS 1997;11:305-10.
14. Michael NL, Chang G, Louis LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997;3:338-40.